Frequency of Tuberculosis in Psoriasis Patients

Assessment of Efficacy and Safety of Secukinumab in Adult Patients in Turkish Population

NCT02795416 ·Status: WITHDRAWN ·Phase: PHASE3

Study to Evaluate Psoriasis Severity and Its Psychosocial Impact Using the Simplified Psoriasis Index (SPI), as Well as Long-term Safety, Tolerability and Efficacy of Secukinumab Administered Subcutaneously in Patients With Moderate to Severe Psoriasis

NCT02595970 ·Status: COMPLETED ·Phase: PHASE3

Study of Efficacy and Safety of Secukinumab in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis

NCT03066609 ·Status: COMPLETED ·Phase: PHASE3

Response to Ustekinumab for Anti-tnf Induced Psoriasiform Skin Lesions

NCT03629379 ·Status: COMPLETED ·Phase: PHASE4

A Study Comparing the Risk of Serious Infections and Malignancies With Deucravacitinib or Biologics in Japanese Patients With Psoriasis

NCT06952465 ·Status: ACTIVE_NOT_RECRUITING

Comparing Efficacy and Safety of Bmab 1200 and Stelara in Patients With Moderate to Severe Chronic Plaque Psoriasis

NCT05335356 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Adult Patients With Chronic Plaque Psoriasis

NCT03230292 ·Status: COMPLETED ·Phase: PHASE2

Pharmacokinetic, Efficacy, Safety, and Immunogenicity of AVT02 With Moderate to Severe Chronic Plaque Psoriasis

NCT04453137 ·Status: COMPLETED ·Phase: PHASE3

Characterization of the Fungal Immunopeptidome Involved in the Immunopathological Mechanisms of Psoriasis

NCT06610942 ·Status: NOT_YET_RECRUITING

Efficacy and Safety of Ustekinumab in Patients With Moderate to Severe Palmar Plantar Psoriasis

NCT01090063 ·Status: COMPLETED ·Phase: NA

Study to Evaluate Effectiveness and Safety in Subjects With Moderate to Severe Psoriasis

NCT02931838 ·Status: COMPLETED ·Phase: PHASE2

Study of Psoriatic Arthritis

NCT00001420 ·Status: COMPLETED

Efficacy, Safety and Immunogenicity of BI 695501 Versus Humira® in Patients With Moderate to Severe Chronic Plaque Psoriasis

NCT02850965 ·Status: COMPLETED ·Phase: PHASE3

Randomized Double-Blind Placebo-Controlled Trial Using Recombinant Human Interleukin-10 for Moderate-to-Severe Psoriasis

NCT00001797 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Effect of Bimekizumab on Gene Expression Biomarkers in Study Participants With Moderate to Severe Plaque Psoriasis

NCT06506916 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Secukinumab Study in PSOriasis Exploring pruRITUS Intensity and Lesional Biomarkers

NCT02362789 ·Status: COMPLETED ·Phase: PHASE3

A 24-week, Multicenter, proSpective stUdy to Evaluate the PASI 90 Clinical Response Rate and the Safety PRofile of sEcukinuMab 300 mg in Cw6-negativE and Cw6-positive Patients With Moderate to Severe Chronic Plaque-type Psoriasis (SUPREME)

NCT02394561 ·Status: COMPLETED ·Phase: PHASE3

Multiple Dose Escalation Study In Medically Stable Subjects With Psoriasis

NCT01736696 ·Status: COMPLETED ·Phase: PHASE1

Efficacy of Secukinumab Compared to Ustekinumab in Adults With Active Psoriatic Arthritis and Failure of TNFα-Inhibitor Treatment

NCT04632927 ·Status: COMPLETED ·Phase: PHASE3

The Impact of Targeted Therapy on Microorganism in Patients With Psoriasis

NCT01504113 ·Status: UNKNOWN

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT03598790 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Evaluation of Anti-CD20 Monoclonal Antibody Combined with Azathioprine and Corticosteroids in the Treatment of Pemphigus Vulgaris

NCT06654817 ·Status: COMPLETED

A Study to Evaluate the Efficacy and Safety of LZM012

NCT06110676 ·Status: RECRUITING ·Phase: PHASE3

Regulation of Inflammatory Genes in Psoriasis

NCT03125655 ·Status: RECRUITING

A Study to Provide Real-world Evidence on the Treatment Goal Achievement Rate, Adherence to and Utilization Patterns of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in Greece

NCT02713295 ·Status: COMPLETED